menu search

Clearside biomedical positive oasis and extension study data presented at the retina society 56th annual scientific meeting

– Excellent Safety Profile, Stable Vision, and Reduced Frequency of Injections Observed for up to 6 months – – ODYSSEY Phase 2b Clinical Trial E...

October 16, 2023, 11:05 am

Olema oncology announces phase 2 monotherapy clinical results to be presented at the 2023 esmo congress

Oral presentation by Dr. Nancy U. Lin from Dana-Farber Cancer Institute at 8:55 a.m. CEST/2:55 a.m. ET on October 22, 2023Olema will host an investor ...

October 16, 2023, 11:02 am

Omega therapeutics presents new preclinical data supporting the potential of otx-2101 in combination settings for treatment of nsclc

Combination of a MYC-targeting epigenomic controller with immune checkpoint or EGFR inhibitor enhanced anti-tumor activity in models of NSCLC CAMBRIDG...

October 16, 2023, 11:00 am

Why manchester united stock is taking a loss today

It appears Manchester United will not be sold outright, meaning small shareholders will not get a chance to cash in. The deal that is happening repres...

October 16, 2023, 10:46 am

Hillcrest pursuing investment and commercialization opportunities in the uk

Hillcrest Energy Technologies Ltd (CSE:HEAT, OTCQB:HLRTF) told shareholders that its leadership team, including CEO Don Currie, strategic advisor Dan ...

October 16, 2023, 10:37 am

Volitionrx to present cancer detection abstracts at european oncology conference

VolitionRx (NYSE-A:VNRX) said it will be presenting three scientific abstracts about cancer detection tools at the annual congress of the European Soc...

October 16, 2023, 10:11 am

Verses ai ceo & founder to participate in upcoming conferences

Lytham Partners Fall 2023 Investor Conference, Tuesday Oct 17th ThinkEquity 2023 Conference, Thursday Oct 19th in NYC VANCOUVER, British Columbia, Oct...

October 16, 2023, 9:44 am

Ideal power announces plans for upcoming investor conferences

MicroCap Rodeo Fall Foliage Virtual Conference on October 24, 26 and 27, 2023 Emerging Growth Virtual Conference on November 1, 2023 The Benchmark Com...

October 16, 2023, 9:20 am

Invinity chief says vanadium presents ‘a real alternative' to lithium batteries

In a recent interview, chief executive of Invinity Energy Systems PLC (AIM:IES, OTCQX:IESVF) Larry Zulch unveiled two significant developments in the...

October 16, 2023, 7:09 am

Pennon, seven trent and united utilities liked by jefferies

Pennon Group PLC (LSE:PNN, OTC:PEGRY), United Utilities Group PLC (LSE:UU.) and Severn Trent PLC (LSE:SVT)'s business plans ...

October 16, 2023, 7:09 am

Kiora pharmaceuticals to participate in the lytham partners fall 2023 investor conference

Encinitas, California--(Newsfile Corp. - October 16, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) invites investors to view the Company's online prese...

October 16, 2023, 7:00 am

Spi energy's solar4america heads to ft. lauderdale to present products and plans at re+ florida

MCCLELLAN PARK, CA / ACCESSWIRE / October 16, 2023 / SPI Energy Co., Ltd., (NASDAQ:SPI) (the "Company"), a global renewable energy company and provide...

October 16, 2023, 3:45 am

Biontech to present multiple program updates across modalities at esmo congress 2023

MAINZ, Germany, October 16, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will pres...

October 16, 2023, 3:30 am

Merck to present latest research from oncology portfolio at esmo 2023

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that 28 abstracts featuring the latest research ...

October 16, 2023, 2:00 am

Arvinas announces upcoming bavdegalutamide poster presentation at esmo congress 2023

NEW HAVEN, Conn., Oct. 15, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drug...

October 15, 2023, 10:07 pm

Regeneron to showcase progress from innovative oncology portfolio in several difficult-to-treat cancers at esmo

Event-free survival of investigational use of Libtayo® (cemiplimab) in neoadjuvant cutaneous squamous cell carcinoma (CSCC) from Phase 2 trial to be ...

October 15, 2023, 10:05 pm

Precede biosciences announces first scientific data from its liquid biopsy platform to be presented as an oral presentation at esmo 2023

Data from more than 400 patients across 15 cancers demonstrate the significance of the Precede approach to informing therapeutic decision making and c...

October 15, 2023, 10:05 pm

Arvinas and pfizer announce upcoming vepdegestrant (arv-471) poster presentation at esmo congress 2023

NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced they will <...

October 15, 2023, 10:05 pm

Comptia shares insights on evolving cybersecurity with tech leaders in australia

Chief Technology Evangelist Dr. James Stanger scheduled to speak Oct 17 at Australian Cyber Conference MELBOURNE, AUSTRALIA, Oct. 15, 2023 (GLOBE NEWS...

October 15, 2023, 10:00 pm

Palestinian authority president said actions of hamas don't represent palestinian people

Reuters with the report of comments from Palestinian Authority President Mahmoud Abbas.He said the actions and policies of Hamas do not re...

October 15, 2023, 9:04 pm


Search within

Pages Search Results: